About Us

Polytherapeutics, Inc. (PTI) is a privately owned New Jersey Corporation having a registered business office in Bridgewater, NJ and a research & development laboratory at the New Brunswick Technology Center in New Brunswick, NJ.  PTI was founded in 1997 by Kishore R. Shah, Ph.D. for the development and commercialization of controlled release technologies and products based on his concepts of novel polymeric materials.

The mission of Polytherapeutics is to conduct research and development of unique value added and patent protected technologies and healthcare products targeted at meeting unsatisfied customer needs to enhance their quality of life.  Specific mission is to develop and commercialize health and beauty products based on PTI’s unique bioadhesive actives delivery technology (PharmaDur®).  The business objective is to forge strategic alliances (R&D collaborations and licensing by product or field of use) with other businesses in the pharmaceutical and personal care industry for worldwide marketing of the products of PTI’s technologies.

Currently marketed products by licensees include Rx dermatological products and several cosmetic skincare products.  Research collaborations include projects pertaining to transdermal and ophthalmic drug delivery.